On one hand, IDH1mut generation of D-2-HG can trigger gliomagenesis by interfering with DNA/histone methylation, HIF1α, and DNA damage repair, while on the other acting as a growth suppressor of established gliomas (4–7), via mechanisms such as FTO inhibition. This evidence concerns the gene FTO and central nervous system cancer.